RUA — Rua Bioscience Income Statement
0.000.00%
Last trade - 00:00- NZ$6.02m
- NZ$5.99m
- NZ$0.09m
Annual income statement for Rua Bioscience, fiscal year end - June 30th, NZD millions except per share, conversion factor applied.
R2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0.024 | 0.358 | 0.086 |
| Cost of Revenue | |||||
| Gross Profit | — | — | -0.104 | 0.018 | -0.118 |
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3.62 | 6.19 | 7.61 | 6.5 | 13.9 |
| Operating Profit | -3.62 | -6.19 | -7.58 | -6.14 | -13.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -3.6 | -6.17 | -7.49 | -5.96 | -13.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.81 | -4.42 | -8.64 | -5.96 | -13.7 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.81 | -4.42 | -8.64 | -5.96 | -13.7 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.81 | -4.42 | -8.64 | -5.96 | -13.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.017 | -0.03 | -0.051 | -0.033 | -0.024 |